Recombinant human interleukin 11 (Neumega(R)) is tolerated at double the adult dose and enhances hematopoietic recovery following ifosfamide, carboplatin and etoposide (ICE) chemotherapy in children: Correlation with rapid clearance, lack of induction of inflammatory cytokines and mobilization of early progenitor cells.
Conferences
Kirov, I; Goldman, S; Blazar, B; vandeVen, C; Davenport, G; Reaman, G; Laver, J; Kreissman, S; Berg, S; Kaye, J; Patterson, F; Hutabarat, R ...
Published in: BLOOD
November 15, 1997
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 15, 1997
Volume
90
Issue
10
Start / End Page
2584 / 2584
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kirov, I., Goldman, S., Blazar, B., vandeVen, C., Davenport, G., Reaman, G., … Cairo, M. S. (1997). Recombinant human interleukin 11 (Neumega(R)) is tolerated at double the adult dose and enhances hematopoietic recovery following ifosfamide, carboplatin and etoposide (ICE) chemotherapy in children: Correlation with rapid clearance, lack of induction of inflammatory cytokines and mobilization of early progenitor cells. In BLOOD (Vol. 90, pp. 2584–2584).
Kirov, I., S. Goldman, B. Blazar, C. vandeVen, G. Davenport, G. Reaman, J. Laver, et al. “Recombinant human interleukin 11 (Neumega(R)) is tolerated at double the adult dose and enhances hematopoietic recovery following ifosfamide, carboplatin and etoposide (ICE) chemotherapy in children: Correlation with rapid clearance, lack of induction of inflammatory cytokines and mobilization of early progenitor cells.” In BLOOD, 90:2584–2584, 1997.
Kirov I, Goldman S, Blazar B, vandeVen C, Davenport G, Reaman G, et al. Recombinant human interleukin 11 (Neumega(R)) is tolerated at double the adult dose and enhances hematopoietic recovery following ifosfamide, carboplatin and etoposide (ICE) chemotherapy in children: Correlation with rapid clearance, lack of induction of inflammatory cytokines and mobilization of early progenitor cells. In: BLOOD. 1997. p. 2584–2584.
Kirov, I., et al. “Recombinant human interleukin 11 (Neumega(R)) is tolerated at double the adult dose and enhances hematopoietic recovery following ifosfamide, carboplatin and etoposide (ICE) chemotherapy in children: Correlation with rapid clearance, lack of induction of inflammatory cytokines and mobilization of early progenitor cells.” BLOOD, vol. 90, no. 10, 1997, pp. 2584–2584.
Kirov I, Goldman S, Blazar B, vandeVen C, Davenport G, Reaman G, Laver J, Kreissman S, Berg S, Kaye J, Patterson F, Hutabarat R, Dykstra K, Cairo MS. Recombinant human interleukin 11 (Neumega(R)) is tolerated at double the adult dose and enhances hematopoietic recovery following ifosfamide, carboplatin and etoposide (ICE) chemotherapy in children: Correlation with rapid clearance, lack of induction of inflammatory cytokines and mobilization of early progenitor cells. BLOOD. 1997. p. 2584–2584.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 15, 1997
Volume
90
Issue
10
Start / End Page
2584 / 2584
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology